Matrix Metalloproteinases as Potential Targets in the Venous Dilation Associated with Varicose Veins
Identifieur interne : 003416 ( Main/Exploration ); précédent : 003415; suivant : 003417Matrix Metalloproteinases as Potential Targets in the Venous Dilation Associated with Varicose Veins
Auteurs : Arda Kucukguven ; Raouf A. KhalilSource :
- Current drug targets [ 1389-4501 ] ; 2013.
Abstract
Varicose veins (VVs) are a common venous disease of the lower extremity characterized by incompetent valves, venous reflux, and dilated and tortuous veins. If untreated, VVs could lead to venous thrombosis, thrombophlebitis and chronic venous leg ulcers. Various genetic, hormonal and environmental factors may lead to structural changes in the vein valves and make them incompetent, leading to venous reflux, increased venous pressure and vein wall dilation. Prolonged increases in venous pressure and vein wall tension are thought to increase the expression/activity of matrix metalloproteinases (MMPs). Members of the MMPs family include collagenases, gelatinases, stromelysins, matrilysins, membrane-type MMPs and others. MMPs are known to degrade various components of the extracellular matrix (ECM). MMPs may also affect the endothelium and vascular smooth muscle, causing changes in the vein relaxation and contraction mechanisms. ECs injury also triggers leukocyte infiltration, activation and inflammation, which lead to further vein wall damage. The vein wall dilation and valve dysfunction, and the MMP activation and superimposed inflammation and fibrosis would lead to progressive venous dilation and VVs formation. Surgical ablation is an effective treatment for VVs, but may be associated with high recurrence rate, and other less invasive approaches that target the cause of the disease are needed. MMP inhibitors including endogenous tissue inhibitors (TIMPs) and pharmacological inhibitors such as zinc chelators, doxycycline, batimastat and marimastat, have been used as diagnostic and therapeutic tools in cancer, autoimmune and cardiovascular disease. However, MMP inhibitors may have side effects especially on the musculoskeletal system. With the advent of new genetic and pharmacological tools, specific MMP inhibitors with fewer undesirable effects could be useful to retard the progression and prevent the recurrence of VVs.
Url:
PubMed: 23316963
PubMed Central: 3584231
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 003450
- to stream Pmc, to step Curation: 003449
- to stream Pmc, to step Checkpoint: 002163
- to stream Ncbi, to step Merge: 005515
- to stream Ncbi, to step Curation: 005515
- to stream Ncbi, to step Checkpoint: 005515
- to stream Main, to step Merge: 003422
- to stream Main, to step Curation: 003416
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Matrix Metalloproteinases as Potential Targets in the Venous Dilation Associated with Varicose Veins</title>
<author><name sortKey="Kucukguven, Arda" sort="Kucukguven, Arda" uniqKey="Kucukguven A" first="Arda" last="Kucukguven">Arda Kucukguven</name>
</author>
<author><name sortKey="Khalil, Raouf A" sort="Khalil, Raouf A" uniqKey="Khalil R" first="Raouf A." last="Khalil">Raouf A. Khalil</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">23316963</idno>
<idno type="pmc">3584231</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584231</idno>
<idno type="RBID">PMC:3584231</idno>
<date when="2013">2013</date>
<idno type="wicri:Area/Pmc/Corpus">003450</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">003450</idno>
<idno type="wicri:Area/Pmc/Curation">003449</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">003449</idno>
<idno type="wicri:Area/Pmc/Checkpoint">002163</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">002163</idno>
<idno type="wicri:Area/Ncbi/Merge">005515</idno>
<idno type="wicri:Area/Ncbi/Curation">005515</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">005515</idno>
<idno type="wicri:doubleKey">1389-4501:2013:Kucukguven A:matrix:metalloproteinases:as</idno>
<idno type="wicri:Area/Main/Merge">003422</idno>
<idno type="wicri:Area/Main/Curation">003416</idno>
<idno type="wicri:Area/Main/Exploration">003416</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Matrix Metalloproteinases as Potential Targets in the Venous Dilation Associated with Varicose Veins</title>
<author><name sortKey="Kucukguven, Arda" sort="Kucukguven, Arda" uniqKey="Kucukguven A" first="Arda" last="Kucukguven">Arda Kucukguven</name>
</author>
<author><name sortKey="Khalil, Raouf A" sort="Khalil, Raouf A" uniqKey="Khalil R" first="Raouf A." last="Khalil">Raouf A. Khalil</name>
</author>
</analytic>
<series><title level="j">Current drug targets</title>
<idno type="ISSN">1389-4501</idno>
<idno type="eISSN">1873-5592</idno>
<imprint><date when="2013">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p id="P1">Varicose veins (VVs) are a common venous disease of the lower extremity characterized by incompetent valves, venous reflux, and dilated and tortuous veins. If untreated, VVs could lead to venous thrombosis, thrombophlebitis and chronic venous leg ulcers. Various genetic, hormonal and environmental factors may lead to structural changes in the vein valves and make them incompetent, leading to venous reflux, increased venous pressure and vein wall dilation. Prolonged increases in venous pressure and vein wall tension are thought to increase the expression/activity of matrix metalloproteinases (MMPs). Members of the MMPs family include collagenases, gelatinases, stromelysins, matrilysins, membrane-type MMPs and others. MMPs are known to degrade various components of the extracellular matrix (ECM). MMPs may also affect the endothelium and vascular smooth muscle, causing changes in the vein relaxation and contraction mechanisms. ECs injury also triggers leukocyte infiltration, activation and inflammation, which lead to further vein wall damage. The vein wall dilation and valve dysfunction, and the MMP activation and superimposed inflammation and fibrosis would lead to progressive venous dilation and VVs formation. Surgical ablation is an effective treatment for VVs, but may be associated with high recurrence rate, and other less invasive approaches that target the cause of the disease are needed. MMP inhibitors including endogenous tissue inhibitors (TIMPs) and pharmacological inhibitors such as zinc chelators, doxycycline, batimastat and marimastat, have been used as diagnostic and therapeutic tools in cancer, autoimmune and cardiovascular disease. However, MMP inhibitors may have side effects especially on the musculoskeletal system. With the advent of new genetic and pharmacological tools, specific MMP inhibitors with fewer undesirable effects could be useful to retard the progression and prevent the recurrence of VVs.</p>
</div>
</front>
</TEI>
<affiliations><list></list>
<tree><noCountry><name sortKey="Khalil, Raouf A" sort="Khalil, Raouf A" uniqKey="Khalil R" first="Raouf A." last="Khalil">Raouf A. Khalil</name>
<name sortKey="Kucukguven, Arda" sort="Kucukguven, Arda" uniqKey="Kucukguven A" first="Arda" last="Kucukguven">Arda Kucukguven</name>
</noCountry>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003416 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003416 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Main |étape= Exploration |type= RBID |clé= PMC:3584231 |texte= Matrix Metalloproteinases as Potential Targets in the Venous Dilation Associated with Varicose Veins }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:23316963" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
![]() | This area was generated with Dilib version V0.6.31. | ![]() |